Augmenix Secures $15,000,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f0adf7a0-4bf1-44dd-be3e-299c0ed232b0&Preview=1 -
Date
5/12/2011 -
Company Name
Augmenix -
Mailing Address
204 2nd Avenue Waltham, MA 02451 -
Company Description
Augmenix, Inc. is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Augmenix, Inc.’s initial product will be the first synthetic tissue spacer designed and indicated to reduce radiation exposure of normal tissues adjacent to prostate cancers. -
Website
http://www.augmenix.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The agreement also provides Varian with the exclusive option to acquire the rest of Augmenix provided certain agreed-upon milestones have been met. -
M&A Terms
-
Venture Investor
Varian Medical Systems
